Publication | Closed Access

The CRF-like peptide urocortin greatly attenuates loss of extracellular striatal dopamine in rat models of Parkinson's disease by activating CRF1 receptors

Extracellular Striatal DopamineMedicinePhysiologyCrf1 ReceptorsNeuropeptide ReceptorNeuropharmacologyNeuroscienceNervous SystemDopaminePharmacologyNeurochemistryCrf-like Peptide UrocortinNeuropeptides